Chemotherapy vasospasm
WebJul 9, 2024 · Toxicities of cancer treatment, including chemotherapy and radiotherapy, also contribute to endothelial injury and vasospasm, as described in the European Society of … WebApr 12, 2024 · Discussion. Chemotherapy-induced coronary vasospasm was suspected in the patient in this case. After his cardiac catheterization revealed minimal coronary artery disease, the diagnosis was made.Spontaneous coronary artery dissection and acute plaque rupture can be diagnosed on cardiac catheterization, and each has a different …
Chemotherapy vasospasm
Did you know?
WebThis disease is chronic and may experience remissions and relapses over time. Platelets are formed normally and are not destroyed by natural cell death, but by the body's immune system. The increased production of platelets is associated with hypercoagulopathic states. The nurse is caring for a patient with a primary disorder of hemostasis. WebDec 19, 2024 · Vascular toxicity is one of serious complications following cisplatin-based chemotherapy. 1, 2 Early case reports suggested the association between cisplatin and coronary vasospasm. 3, 4 Coronary vasospasm in those reports was diagnosed by transient ST segment elevation without organic coronary stenosis. 5, 6 On the other …
WebNational Center for Biotechnology Information WebNov 16, 2024 · Overview. Vasospasm refers to the sudden contraction of the muscular walls of an artery. It causes the artery to narrow, reducing the amount of blood that can …
WebVasospasm is best treated with vasodilator therapy (drugs that open blood vessels). The most effective and popular vasodilator therapy continues to be the calcium channel blockers (e.g., nifedipine). Studies demonstrate that the calcium channel blockers can reduce the frequency of Raynaud’s phenomenon attacks and reduce the occurrence of ... WebST elevation resolved with nitroglycerin and that supported the diagnosis of coronary vasospasm. The development of ventricular tachycardia was likely secondary to the cardiotoxic effect of cisplatin and to myocardial ischemia from active recurrent coronary vasospasm. Tachyarrhythmia is a known side effect of cisplatin therapy.
WebSep 1, 2024 · Coronary vasospasm attributed to this combination of chemotherapy has never before been reported. Additionally, our case and other available literature demonstrate the efficacy of dihydropyridine calcium channel blocker therapy in treatment of vasospasm induced by chemotherapeutic agents.
WebFeb 1, 2016 · We report on 2 patients who developed widespread cerebral vasospasm and arterial ischemic strokes (AIS) after application of intrathecal (IT) cytarabine. In a 3-year-old child with acute lymphoblastic leukemia (ALL), left leg weakness, hyperreflexia, and clonus were noted 4 days after her first dose of IT cytarabine during the induction phase of her … hotbox broad rippleWebApr 12, 2024 · Discussion. Chemotherapy-induced coronary vasospasm was suspected in the patient in this case. After his cardiac catheterization revealed minimal coronary artery … hotbox bistroWebSep 1, 2024 · Coronary vasospasm attributed to this combination of chemotherapy has never before been reported. Additionally, our case and other available literature … ptcb rescheduleWebJun 28, 2024 · Chest Pain and Chemotherapy: 5-FU Induced Coronary Vasospasm. Written by Salim Rezaie. REBEL EM. Medical Category: Cardiovascular. 58 y/o female … hotbox baked biscottiWebJul 1, 2016 · Heart failure and heart muscle toxicity induced by chemotherapy, particularly anthracyclines and HER2 receptor antagonists, have benefited from an expanding recognition and evidence base to inform strategies to mitigate the risk of this potentially devastating complication. ... Cisplatin also has the potential to provoke vasospasm, … hotbox beaverton hoursWebNov 16, 2024 · Overview. Vasospasm refers to the sudden contraction of the muscular walls of an artery. It causes the artery to narrow, reducing the amount of blood that can flow through it. The tissue receiving ... hotbox birminghamWebINTRODUCTION: 5-Fluorouracil (5FU) is the third most commonly used chemotherapeutic agent in the treatment of solid malignancies, particularly colorectal and pancreatic … ptcb scaled score